| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $112K | -90.2% |
| SG&A Expense | $1.2M | -52.6% |
| Operating Income | -$2.2M | +41.8% |
| Pre-tax Income | -$2.4M | +45.5% |
| Net Income | -$2.4M | +44.7% |
| EPS (Basic) | -$0.02 | +33.3% |
| EPS (Diluted) | -$0.02 | +33.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $5K | -80.2% |
| Total Assets | $139K | +0.8% |
| Current Liabilities | $1.9M | -40.6% |
| Total Liabilities | $1.9M | -40.6% |
| Stockholders' Equity | -$1.8M | +42.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$56K | +92.8% |
| Investing Cash Flow | -$28K | +36.4% |
| Financing Cash Flow | $63K | -88.6% |